The current work examined the potential of using ARV-825 and ABBV-744 to raise the effectiveness of tamoxifen or fulvestrant as well as palbociclib. ARV-825 was effective in both of those p53 wild-style (WT) breast tumor cells As well as in cells lacking useful p53 either by itself or in combination https://theodorem776yjv9.mappywiki.com/user